No abstract available
MeSH terms
-
Administration, Oral
-
Animals
-
Atrial Fibrillation / complications
-
Clinical Trials, Phase III as Topic
-
Drug Design*
-
Factor Xa Inhibitors*
-
Fibrinolytic Agents* / administration & dosage
-
Fibrinolytic Agents* / classification
-
Fibrinolytic Agents* / pharmacology
-
Humans
-
Intracranial Thrombosis / etiology
-
Intracranial Thrombosis / prevention & control
-
Postoperative Complications / prevention & control
-
Pyridines* / administration & dosage
-
Pyridines* / pharmacology
-
Secondary Prevention
-
Thiazoles* / administration & dosage
-
Thiazoles* / pharmacology
-
Thrombosis / drug therapy*
-
Venous Thrombosis / prevention & control
Substances
-
Factor Xa Inhibitors
-
Fibrinolytic Agents
-
Pyridines
-
Thiazoles
-
edoxaban